Feedback / Questions
OPB-101 - Outpace Bio
trIL-12 based cell therapy - Outpace Bio, Lyell Immunopharma
https://www.globenewswire.com/news-release/2024/04/04/2857642/0/en/Outpace-Bio-Announces-Multiple-Presentations-at-the-2024-American-Association-of-Cancer-Research-AACR-Annual-Meeting.html
Apr 4, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next